BAMF
DXCM icon

BI Asset Management Fondsmaeglerselskab’s DexCom DXCM Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Buy
159,357
+139,458
+701% +$9.29M 0.09% 186
2026
Q1 		$1.25M Sell
19,899
-47,559
-71% -$3.31M 0.01% 458
2025
Q4 		$4.48M Buy
67,458
+12,578
+23% +$813K 0.04% 289
2025
Q3 		$3.69M Sell
54,880
-4,296
-7% -$340K 0.03% 309
2025
Q2 		$5.17M Buy
59,176
+2,361
+4% +$185K 0.05% 250
2025
Q1 		$3.88M Buy
56,815
+18,221
+47% +$1.49M 0.04% 259
2024
Q4 		$3M Buy
38,594
+13,782
+56% +$1.02M 0.03% 289
2024
Q3 		$1.66M Buy
24,812
+1,501
+6% +$123K 0.03% 307
2024
Q2 		$2.64M Buy
23,311
+12,691
+120% +$1.6M 0.04% 262
2024
Q1 		$1.47M Buy
10,620
+3,137
+42% +$394K 0.03% 302
2023
Q4 		$929K Sell
7,483
-14,524
-66% -$1.48M 0.02% 403
2023
Q3 		$2.05M Buy
22,007
+14,116
+179% +$1.59M 0.05% 247
2023
Q2 		$1.01M Sell
7,891
-49,526
-86% -$5.99M 0.02% 354
2023
Q1 		$6.67M Buy
57,417
+42,573
+287% +$4.77M 0.18% 112
2022
Q4 		$1.68M Sell
14,844
-273
-2% -$30K 0.04% 251
2022
Q3 		$1.22M Buy
15,117
+1,397
+10% +$118K 0.06% 170
2022
Q2 		$1.02M Buy
13,720
+6,884
+101% +$628K 0.04% 226
2022
Q1 		$874K Sell
6,836
-5,276
-44% -$577K 0.03% 250
2021
Q4 		$1.63M Sell
12,112
-24,620
-67% -$3.54M 0.06% 205
2021
Q3 		$5.02M Buy
36,732
+21,200
+136% +$2.67M 0.19% 119
2021
Q2 		$1.66M Hold
15,532
– – 0.06% 204
2021
Q1 		$1.4M Sell
15,532
-4,516
-23% -$424K 0.06% 225
2020
Q4 		$1.85M Sell
20,048
-23,132
-54% -$2.07M 0.08% 167
2020
Q3 		$4.45M Buy
43,180
+8,352
+24% +$873K 0.2% 104
2020
Q2 		$3.53M Buy
34,828
+16,528
+90% +$1.48M 0.18% 114
2020
Q1 		$1.23M Sell
18,300
-10,680
-37% -$665K 0.07% 216
2019
Q4 		$1.58M Buy
28,980
+25,004
+629% +$1.19M 0.08% 217
2019
Q3 		$148K Sell
3,976
-1,372
-26% -$53.3K 0.01% 343
2019
Q2 		$200K Buy
+5,348
New +$168K 0.01% 222

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's DXCM Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its DexCom (DXCM) stake by 701% in Q2 2026, buying an estimated $9.29M and bringing the position to 159,357 shares worth $10.7M. The position accounts for 0.09% of the portfolio, ranked #186.

BI Asset Management Fondsmaeglerselskab first reported a position in DXCM in Q2 2019 and has held it in 29 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 159,357 shares of DexCom worth $10.7M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab bought 139,458 DexCom shares in Q2 2026, an estimated $9.29M.
  • DexCom made up 0.09% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #186 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in DexCom in Q2 2019 and has held it in 29 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.